Cat Hyperthyroidism and Concurrent Kidney Disease

Managing hyperthyroidism in cats with concurrent chronic kidney disease presents a welfare challenge because treating one condition can worsen the other.

Key Facts

Hyperthyroidism increases glomerular filtration rate, meaning kidney disease may be masked before treatment
Treating hyperthyroidism normalises blood flow to the kidneys, potentially unmasking pre-existing CKD
Approximately 40% of treated hyperthyroid cats develop overt CKD after normalisation of thyroid function
The therapeutic challenge is to control hyperthyroidism adequately while managing emerging kidney disease
Radioactive iodine treatment is the gold standard for hyperthyroidism but cannot be reversed if CKD emerges

Welfare Considerations

The hyperthyroidism-CKD interaction creates a complex welfare dilemma. Untreated hyperthyroidism causes weight loss, muscle wasting, hypertension, and cardiac disease — all reducing welfare. But treatment can unmask kidney disease that worsens progressively. A staged approach — trialling medical treatment with methimazole before committing to irreversible radioiodine — allows assessment of CKD severity before choosing permanent therapy. Cats with both conditions require careful balancing of treatment intensity to maximise quality of life, often requiring ongoing monitoring of both thyroid and kidney function.

What You Can Do

Always test kidney function before and after initiating hyperthyroidism treatment in older cats
Use a trial period of medical management with methimazole before radioiodine in cats at CKD risk
Monitor blood pressure, weight, and kidney values every 3-6 months in cats receiving hyperthyroid treatment
Work with a veterinary internist experienced in concurrent hyperthyroidism and CKD management